SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 144 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.74 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,997,369 | -4.8% | 86,392 | +7.9% | 0.00% | 0.0% |
| Q2 2023 | $2,098,832 | +140478.2% | 80,047 | +38.0% | 0.00% | 0.0% |
| Q1 2023 | $1,493 | -1.1% | 57,991 | -0.1% | 0.00% | 0.0% |
| Q4 2022 | $1,510 | -99.9% | 58,053 | +9.3% | 0.00% | 0.0% |
| Q3 2022 | $1,515,000 | +27.2% | 53,114 | +9.8% | 0.00% | 0.0% |
| Q2 2022 | $1,191,000 | -31.1% | 48,361 | +57.9% | 0.00% | 0.0% |
| Q1 2022 | $1,729,000 | -5.5% | 30,629 | +3.7% | 0.00% | 0.0% |
| Q4 2021 | $1,830,000 | -1.8% | 29,528 | +0.5% | 0.00% | -33.3% |
| Q3 2021 | $1,864,000 | -20.5% | 29,388 | +3.3% | 0.00% | 0.0% |
| Q2 2021 | $2,345,000 | +22.3% | 28,460 | +9.2% | 0.00% | 0.0% |
| Q1 2021 | $1,917,000 | -5.1% | 26,062 | -6.4% | 0.00% | 0.0% |
| Q4 2020 | $2,019,000 | +75.0% | 27,837 | +15.0% | 0.00% | +50.0% |
| Q3 2020 | $1,154,000 | -0.6% | 24,206 | -12.4% | 0.00% | 0.0% |
| Q2 2020 | $1,161,000 | +250.8% | 27,644 | +125.6% | 0.00% | +100.0% |
| Q1 2020 | $331,000 | -8.8% | 12,252 | +30.0% | 0.00% | 0.0% |
| Q4 2019 | $363,000 | – | 9,426 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 5,831,307 | $480,558,000 | 31.49% |
| Consonance Capital Management LP | 1,199,339 | $98,838,000 | 11.90% |
| Boxer Capital, LLC | 2,075,905 | $171,075,000 | 6.04% |
| Perceptive Advisors | 9,699,824 | $799,362,000 | 5.19% |
| Orbimed Advisors | 6,044,266 | $498,108,000 | 5.04% |
| Samsara BioCapital, LLC | 169,852 | $13,998,000 | 1.73% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,375,775 | $113,378,000 | 1.50% |
| SPHERA FUNDS MANAGEMENT LTD. | 195,117 | $16,080,000 | 1.09% |
| Artal Group S.A. | 500,000 | $41,205,000 | 0.84% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 558,574 | $46,032,000 | 0.82% |